Skip to main content

$0.059 -0.003 (-4.84%)

High

$0.06

Low

$0.06

Trades

100

Turnover

$254,071

Volume

4,352,698
30 June 2023 at 4:10pm
Register to track ANP and receive email alerts.
Subject
ANP Ann: Trading Halt

ANP Ann: Investor Presentation

ANP Ann: Quarterly Activities/Appendix 4C Cash Flow Report

ANP Ann: ATL1102 DMD Clinical Trial Application Submitted in Europe

ANP Ann: Proteomics and disease marker identification in DMD Webinar

ANP Ann: ANP to Present at the PPMD Annual Conference 2022

ANP Ann: New Indication for ATL1102 Limb Girdle Muscular Dystrophy R2

ANP Ann: Presentation at 2nd Annual Oligonucleotide for CNS Summit

ANP Ann: Investor Presentation

ANP Ann: Bonus Options Issue - Letter to Shareholders

ANP Ann: Change of Director's Interest Notice (CG,MD)

ANP Ann: Notification regarding unquoted securities - ANP

ANP Ann: Quarterly Activities/Appendix 4C Cash Flow Report

ANP Ann: Receipt of R&D Tax Incentive Payment

ANP Ann: Proposed issue of securities - ANP

ANP Ann: Prospectus

ANP Ann: Bonus Option Offer

ANP Ann: Plasma protein data supports bone density improvement in DMD

ANP Ann: Poster Presentation at 2022 MDA Conference

ANP Ann: Long COVID-19 strategic collaboration with US Experts

ANP Ann: Half Yearly Report and Accounts

ANP Ann: ANP to present at XIX International Conference on DMD

ANP Ann: Dosing commenced in MCRI collaboration animal study

ANP Ann: Cleansing Notice

ANP Ann: Application for quotation of securities - ANP

ANP Ann: Proposed issue of securities - ANP

ANP Ann: Quarterly Report and Appendix 4C

ANP Ann: Cleansing Notice

ANP Ann: Application for quotation of securities - ANP

ANP Ann: Proposed issue of securities - ANP

ANP Ann: Change of Director's Interest Notice (MD)

ANP Ann: Notification regarding unquoted securities - ANP

ANP Ann: Application for quotation of securities - ANP

ANP Ann: Entitlement Offer Results

ANP Ann: Appendix 3G

ANP Ann: Final Director's Interest Notice (WG)

ANP Ann: Final Director's Interest Notice (GM, RM)

ANP Ann: Results of Annual General Meeting

ANP Ann: Annual General Meeting Presentation

ANP Ann: Positive UK PIP Decision & PDCO opinion ratification by EMA

ANP Ann: ATL1102 Toxicology Protocol submitted to US FDA

ANP Ann: Entitlement Offer Closing Date Extended

ANP Ann: Update - Proposed issue of securities - ANP

ANP Ann: Notice of Annual General Meeting/Proxy Form

ANP Ann: Change of Director's Interest Notice - CG

ANP Ann: Becoming a substantial holder

ANP Ann: Prospectus

ANP Ann: Application for quotation of securities - ANP

ANP Ann: Placement and Cleansing Notice

ANP Ann: Investor Presentation

Register to track ANP and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL